Arvinas, Inc. (NASDAQ:ARVN) Q1 Earnings Beat, Revenue Miss, and Major FDA Approval
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameArvinas, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









